Reuters logo
BRIEF-Threshold Pharmaceuticals, National Cancer Institute to collaborate on drug candidate TH-3424
December 19, 2016 / 1:26 PM / 9 months ago

BRIEF-Threshold Pharmaceuticals, National Cancer Institute to collaborate on drug candidate TH-3424

Dec 19 (Reuters) - Threshold Pharmaceuticals Inc :

* Threshold Pharmaceuticals Inc - has entered into collaboration with national cancer institute , part of national institutes of health, to study th-3424 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below